Login / Signup

Islet amyloidosis in a child with type 1 diabetes.

Maria L BeeryMichael J HallerMark A AtkinsonAlexandra E ButlerMartha L Campbell-Thompson
Published in: Islets (2019)
Histopathology based studies of the pancreas obtained from organ donors are increasing our awareness of islet phenotypic heterogeneity during development and aging, as well as in settings of type 1 diabetes, type 2 diabetes, monogenic diabetes or other forms of this metabolic disease. Islet amyloidosis represents a histopathological feature classically ascribed to patients with type 2 diabetes. Herein, the occurrence of islet amyloidosis and its severity are reported in a child with type 1 diabetes along with histological comparisons of islet amyloidosis in two young adults with recent-onset type 1 diabetes. Islet amyloidosis was infrequent yet widely distributed throughout the pancreas in the child with type 1 diabetes and both adults with type 1 diabetes, with no such pathology seen in matched control donors. Analysis of these cases add to the increasing appreciation of islet heterogeneity in children and young adults with type 1 diabetes. Such knowledge also supports a notion that multiple pathophysiological mechanisms underlie the loss of functional β-cell mass in the spectrum of clinical phenotypes in patients with type 1 diabetes.
Keyphrases
  • type diabetes
  • young adults
  • glycemic control
  • cardiovascular disease
  • multiple myeloma
  • mental health
  • single cell
  • healthcare
  • insulin resistance
  • bone marrow
  • mesenchymal stem cells
  • kidney transplantation
  • case control